Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 52, Issue 5
Volume 52, Issue 5
1 March 2011
ISSN 1058-4838
EISSN 1537-6591

Volume 52, Issue 5, 1 March 2011

1 March News

Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages i–ii, https://doi.org/10.1093/cid/ciq235

In the Literature

Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages iii–iv, https://doi.org/10.1093/cid/ciq222

IDSA Guideline

Kalpana Gupta and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 561–564, https://doi.org/10.1093/cid/cir102
Kalpana Gupta and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages e103–e120, https://doi.org/10.1093/cid/ciq257

MAJOR ARTICLES AND COMMENTARIES

Julie Jarand and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 565–571, https://doi.org/10.1093/cid/ciq237

M. abscessus pulmonary disease is challenging to manage. The majority of patients respond clinically and microbiologically to antibiotic and/or surgical therapy, but response is often temporary. Surgical resection, in addition to antibiotics, may offer a prolonged microbiologic response.

David E. Griffith
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 572–574, https://doi.org/10.1093/cid/ciq252
Marianne Leruez-Ville and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 575–581, https://doi.org/10.1093/cid/ciq241

High sensitivity and specificity were achieved with 2 cytomegalovirus (CMV) polymerase chain reaction assays in dried blod spots for neonatal screening when assessed in a population of neonates born with symptoms compatible with congenital CMV or born to mothers with a primary infection during pregnancy.

Robert F. Pass
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 582–584, https://doi.org/10.1093/cid/ciq253
Ryan P. Fagan and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 585–592, https://doi.org/10.1093/cid/ciq240

Foodborne botulism remains a public health problem among Alaskan Natives, especially among the female population and older persons. Incidence might be decreasing but remains >800 times the overall US rate. Early diagnosis is critical for timely access to antitoxin and supportive care.

John W. Austin and Daniel Leclair
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 593–594, https://doi.org/10.1093/cid/ciq256
Lely Solari and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 595–603, https://doi.org/10.1093/cid/ciq186

We evaluated 13 clinical prediction rules for respiratory isolation of inpatients with suspicion of tuberculosis. Mylotte s score was the best performing one. It attained a sensitivity of 88.9% and specificity of 63.9% and constitutes a useful tool in resource-constrained settings.

Robert A. Wermers and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 604–611, https://doi.org/10.1093/cid/ciq188

We have identified that in transplant subjects, long term use of voriconazole, a fluoride containing medication, is associated with elevated plasma fluoride levels compared to those not taking it. Fluoride related bone complications were also observed including periostitis and fluorosis.

Nicholas M. Douglas and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 612–620, https://doi.org/10.1093/cid/ciq249

On the Thai-Myanmar border, Plasmodium vivax is the most common cause of parasitological failure following treatment for acute falciparum malaria. Slowly eliminated antimalarials significantly reduce the risk of early recurrence.

J. Kevin Baird
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 621–623, https://doi.org/10.1093/cid/ciq258
Man-Fung Yuen and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 624–632, https://doi.org/10.1093/cid/ciq247

This study using chimeric mice and human tracing methodology demonstrates that although hepatitis B virus transmission is possible through blood transfusion from occult hepatitis B donors, the rate remains low especially if the occult hepatitis B donors are anti-HBs positive.

VIEWPOINTS

Daniel M. Musher and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 633–640, https://doi.org/10.1093/cid/ciq207

Widespread use of pneumococcal conjugate vaccine in infants and children has yielded extraordinary results. On the basis of numerous studies published to date, there is little reason to believe that, in adults, the more expensive conjugate vaccine should replace polysaccharide vaccine.

BRIEF REPORT

LaRee Tracy and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 641–645, https://doi.org/10.1093/cid/ciq190

PHOTO QUIZ

Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 646–647, https://doi.org/10.1093/cid/ciq165

INVITED ARTICLES

James Riddell and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 648–653, https://doi.org/10.1093/cid/ciq204
Lona Mody and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 654–661, https://doi.org/10.1093/cid/ciq205

HIV/AIDS

Marylène Lejeune and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 662–670, https://doi.org/10.1093/cid/ciq197

In most AIDS patients with a history of toxoplasmic encephalitis, combined antiretroviral therapy restored T. gondiispecific CD4 T-cell responses. This finding supports the safety of withdrawing toxoplasma prophylaxis when the CD4+ T-cell count returns to levels above 200/μL.

Laura J. Waters and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 671–673, https://doi.org/10.1093/cid/ciq198
Jason T. Blackard and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 674–680, https://doi.org/10.1093/cid/ciq199

Predictors of liver fibrosis were evaluated in women using a noninvasive index (FIB-4). HIV RNA levels were associated with increased FIB-4 in the absence of viral hepatitis, alcohol use, or antiretroviral therapy. These data complement evidence suggesting a potential relationship between HIV infection and hepatic fibrosis.

Peter W. Hunt and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 681–687, https://doi.org/10.1093/cid/ciq202

Among HIV controllers, higher activated and HIV-specific CD4+ T cell frequencies were strongly associated with a greater burden of pro-viral DNA, suggesting that the very immune response helping control viral replication may be contributing to viral persistence.

PHOTO QUIZ ANSWER

Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 688–689, https://doi.org/10.1093/cid/ciq171

CORRESPONDENCE

Elisabetta Mantengoli and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 690–691, https://doi.org/10.1093/cid/ciq194
Alex Studemeister
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 691–692, https://doi.org/10.1093/cid/ciq219
Zeliang Chen and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages 692–693, https://doi.org/10.1093/cid/ciq231

ELECTRONIC ARTICLES

Katherine B. Gibney and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages e121–e126, https://doi.org/10.1093/cid/ciq214

Chikungunya virus (CHIKV) represents an emerging health threat to the United States as humans amplify CHIKV and vectors that transmit CHIKV are present in the country. To minimize the risk of CHIKV spread in the United States, healthcare providers and public health officials should be educated about recognition, diagnosis, and reporting of CHIK cases.

Masanori Kai and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages e127–e132, https://doi.org/10.1093/cid/ciq217

Though, multi-drug therapy (MDT) has effectively reduced the number of leprosy cases, the rate of reduction has slowed. We show high rates of dapsone resistance in relapse patients in our study. Therefore, early detection of early detection of Mycobacterium leprae and epidemiological study of relapse is relevant in attempts to eliminate the disease.

Michele L. Ramien and others
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Pages e133–e135, https://doi.org/10.1093/cid/ciq213

COVER

Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Page NP, https://doi.org/10.1093/cid/ciq236

STANDING MATERIAL

Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Page NP, https://doi.org/10.1093/cid/cir115
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Page NP, https://doi.org/10.1093/cid/cir116
Clinical Infectious Diseases, Volume 52, Issue 5, 1 March 2011, Page NP, https://doi.org/10.1093/cid/cir117
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close